IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Galectin Therapeutics Inc

CUSIP: 363225111 | 11 institutional holders

Quarters

Q4 2016Q3 2016Q2 2016Q1 2016Q4 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2016

Millennium Management LLC640,800
0.0% of portfolio›$35
Neuberger Berman Group LLC125,919
0.0% of portfolio›$7
UBS Group AG2,112
0.0% of portfolio›$0
Tower Research Capital LLC (TRC)133
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Millennium Management LLC
640,800$350.0%CoreVery HighNew York, NY2017-02-14
Neuberger Berman Group LLC
125,919$70.0%CoreMediumNew York, NY2017-02-06
UBS Group AG
2,112$00.0%CoreMediumZurich, Switzerland2017-02-14
Tower Research Capital LLC (TRC)
133$00.0%GARPVery HighNew York, NY2017-02-03